S
Scott G. Filler
Researcher at University of California, Los Angeles
Publications - 318
Citations - 27186
Scott G. Filler is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Candida albicans & Corpus albicans. The author has an hindex of 75, co-authored 298 publications receiving 24377 citations. Previous affiliations of Scott G. Filler include University of Nebraska Medical Center & Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Peter G. Pappas,Carol A. Kauffman,David R. Andes,Daniel K. Benjamin,Thierry Calandra,John E. Edwards,Scott G. Filler,John F. Fisher,Bart Jan Kullberg,Luis Ostrosky-Zeichner,Annette C. Reboli,John H. Rex,Thomas J. Walsh,Jack D. Sobel +13 more
TL;DR: These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections.
Journal ArticleDOI
Guidelines for Treatment of Candidiasis
Peter G. Pappas,John H. Rex,Jack D. Sobel,Scott G. Filler,William E. Dismukes,Thomas J. Walsh,John E. Edwards +6 more
TL;DR: This work presents a novel and scalable approach that allows for real-time decision-making about whether or not to vaccinate children against infection by a single infectious agent.
Journal ArticleDOI
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Vance G. Fowler,Helen W. Boucher,G. Ralph Corey,Elias Abrutyn,Adolf W. Karchmer,Mark E. Rupp,Donald P. Levine,Henry F. Chambers,Francis P. Tally,Gloria Vigliani,Christopher H. Cabell,Arthur Stanley Link,Ignace DeMeyer,Scott G. Filler,Marcus J. Zervos,Paul P. Cook,Jeffrey Parsonnet,Jack M. Bernstein,Connie S. Price,Graeme N. Forrest,Gerd Fätkenheuer,Marcelo Gareca,Susan J. Rehm,Hans Reinhardt Brodt,Alan D. Tice,Sara E. Cosgrove +25 more
TL;DR: Daptomycin (6 mg per kilogram daily) is not inferior to standard therapy for S. aureus bacteremia and right-sided endocarditis and met prespecified criteria for the noninferiority of daptomecin.
Journal ArticleDOI
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
Heather R. Conti,Fang Shen,Namrata Nayyar,Eileen Stocum,Jianing N. Sun,Matthew J. Lindemann,Allen W. Ho,Justine Hoda Hai,Jeffrey J. Yu,Ji Won Jung,Scott G. Filler,Patricia A. Masso-Welch,Mira Edgerton,Sarah L. Gaffen,Sarah L. Gaffen +14 more
TL;DR: The Th17 lineage, acting largely through IL-17, confers the dominant response to oral candidiasis through neutrophils and antimicrobial factors.
Journal ArticleDOI
Practice Guidelines for the Treatment of Candidiasis
John H. Rex,Thomas J. Walsh,Jack D. Sobel,Scott G. Filler,Peter G. Pappas,William E. Dismukes,John E. Edwards +6 more
TL;DR: This document summarizes current knowledge about treatment of multiple forms of candidiasis and is the guideline of the Infectious Diseases Society of America for the treatment ofCandida, covering 4 major topical areas.